FIELD: medicine, gastroenterology. SUBSTANCE: 0.5 ml of histaserotoglobulin is injected during fibrogastroduodenoscopy into 4-6 sites radially disposed around the ulcer 0.5 cm against the edge of ulcerous defect at 1-3-d-long interval. Treatment course includes 4-5 seances. EFFECT: faster epithelization and healing of gastroduodenal ulcers, decreased number of relapses. 1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING GASTRODUODENAL PEPTIC ULCERS | 1999 |
|
RU2159125C1 |
METHOD FOR TREATING GASTRODUODENAL PEPTIC ULCERS | 1995 |
|
RU2125897C1 |
METHOD OF DUODENUM ULCER DISEASE TREATMENT | 1993 |
|
RU2082413C1 |
METHOD FOR TREATMENT OF ULCERATIVE DISEASE | 1996 |
|
RU2078531C1 |
METHOD FOR ENDOSCOPIC TREATMENT OF EROSIVE-ULCEROUS LESIONS OF GASTRODUODENAL MUCOSA IN ANGIOCARDIOSURGICAL PATIENTS | 2006 |
|
RU2322242C2 |
ENDOSCOPIC METHOD FOR TREATING PATIENTS FOR GASTRODUODENAL ULCERS WITH DERINATE PREPARATION | 2005 |
|
RU2279882C1 |
METHOD FOR STOPPING HEMORRHAGES FROM GASTRODUODENAL PEPTIC ULCERS | 1999 |
|
RU2159631C1 |
METHOD FOR ENDOSCOPIC TREATMENT OF GASTRODUODENAL ULCERS | 2016 |
|
RU2644934C1 |
METHOD FOR ENDOSCOPIC TREATMENT OF EROSIVE AND ULCERATIVE LESIONS OF THE STOMACH AND DUODENUM | 2021 |
|
RU2763754C1 |
METHOD FOR ENDOSCOPIC TREATMENT OF GASTRODUODENAL ULCER | 2005 |
|
RU2295957C1 |
Authors
Dates
2002-01-20—Published
1999-03-10—Filed